Endothelial Dysfunction in Metabolic Diseases: Role of Oxidation and Possible Therapeutic Employment of N-acetylcysteine

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|21|32|3616-3635

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.21, Iss.32, 2014-10, pp. : 3616-3635

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cysteine Network (CYSTEINET) Dysregulation in Parkinson’s Disease: Role of N-acetylcysteine

By  

Current Drug Metabolism, Vol. 17, Iss. 4, 2016-05 ,pp. : 368-385

Bentham Science Publishers

Access to resources Recommend Favorite

Anaphylactoid reactions to N-acetylcysteine

By Coulson James Michael   Thompson John Paul  

Clinical Toxicology, Vol. 51, Iss. 7, 2013-08 ,pp. : 727-727

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Potential of N-Acetylcysteine for Wound Healing, Acute Bronchiolitis, and Congenital Heart Defects

By  

Current Drug Metabolism, Vol. 17, Iss. 2, 2016-02 ,pp. : 156-167

Bentham Science Publishers

Access to resources Recommend Favorite

Soluble Lectin‐Like Oxidized LDL Receptor 1 as a Possible Mediator of Endothelial Dysfunction in Patients With Metabolic Syndrome

By  

Journal Of Clinical Laboratory Analysis (Electronic), Vol. 29, Iss. 3, 2015-05 ,pp. : 184-190

John Wiley & Sons Inc

Access to resources Recommend Favorite

N-acetylcysteine beneficial in COPD exacerbations

By  

Inpharma, Vol. 1, Iss. 1494, 2005-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite